WuXi XDC Cayman Inc. (HKG:2268)
Hong Kong · Delayed Price · Currency is HKD 70.85
-2.05 (-2.81%)
At close: Jan 16, 2026
WuXi XDC Cayman Market Cap
WuXi XDC Cayman has a market cap or net worth of 88.93 billion as of January 16, 2026. Its market cap has increased by 133.84% in one year.
Market Cap
88.93B
Enterprise Value
85.10B
Revenue
5.58B
Ranking
n/a
PE Ratio
63.35
Stock Price
70.85
Market Cap Chart
Since November 17, 2023, WuXi XDC Cayman's market cap has increased from 33.00B to 88.93B, an increase of 169.53%. That is a compound annual growth rate of 58.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 88.93B | 16.63% |
| Dec 31, 2025 | 76.26B | 107.33% |
| Dec 31, 2024 | 36.78B | -4.03% |
| Dec 29, 2023 | 38.32B | 16.14% |
| Nov 17, 2023 | 33.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 303.05B |
| Hansoh Pharmaceutical Group Company | 259.96B |
| JD Health International | 223.53B |
| WuXi Biologics | 165.34B |
| Innovent Biologics | 155.16B |
| Sino Biopharmaceutical | 127.10B |
| Alibaba Health Information Technology | 125.76B |
| Akeso | 113.67B |